Cabaletta Bio Files 8-K Report
Ticker: CABA · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1759138
Sentiment: neutral
Topics: 8-K, filing, disclosure
TL;DR
Cabaletta Bio filed an 8-K, likely containing important company updates.
AI Summary
On February 18, 2025, Cabaletta Bio, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates Cabaletta Bio is providing updates to the SEC, which could include important operational or financial information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate disclosed material events, suggesting a routine update.
Key Players & Entities
- Cabaletta Bio, Inc. (company) — Registrant
- 0001759138 (company) — Central Index Key
- 2929 Arch Street, Suite 600, Philadelphia, PA 19104 (location) — Business Address
FAQ
What is the primary purpose of this 8-K filing by Cabaletta Bio, Inc.?
The filing is a Current Report on Form 8-K, indicating it reports on significant events or information that a public company is required to disclose. The excerpt specifically mentions 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits'.
When was this 8-K report filed with the SEC?
The report was filed on February 18, 2025.
What is Cabaletta Bio, Inc.'s principal executive office address?
Cabaletta Bio, Inc.'s principal executive offices are located at 2929 Arch Street, Suite 600, Philadelphia, PA 19104.
What is Cabaletta Bio, Inc.'s telephone number?
Cabaletta Bio, Inc.'s telephone number is (267) 759-3100.
What is Cabaletta Bio, Inc.'s state of incorporation?
Cabaletta Bio, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding Cabaletta Bio, Inc. (CABA).